LUCA SPACCAPELO, MD, PHARMACOLOGIST, MBA Graduate with honors in Medicine and Surgery, Luca started his academic career as clinical pharmacologist involved in clinical and research activities at the division of toxicology and clinical pharmacology of the University of Modena and Reggio Emilia. From 2009 and 2012, Luca has been author or co-author of 21 scientific …
Law graduate, with international experience of research in the field of Business Law at Cambridge University and UCL, Nicolò has been a student at Collegio Borromeo of Pavia and a great Medtech and Biotech enthusiast. He acquired experience in this field during a period spent in San Francisco as a selected student from the Mind …
FEDERICA Girolami Federica is Business Development, Scientific Liaison and Drug Safety Director at Rottapharm Biotech, where she is responsible for negotiations, alliances, and licensing activities. In her role as Scientific Liaison, she cultivates relationships with academic researchers and key opinion leaders. Given her long-standing experience in Pharmacovigilance, she is also responsible for all Drug Safety …
Max is Professor of Applied Biology at University of Catania, Italy and director of the laboratory of Systems and Synthetic Biology at the Department of Drug Sciences. He is Medical Doctor with a PhD in Embryology. He was a researcher at CNR (I), MRC (UK), San Raffaele (I), and KCL (UK); he received a Mini-MBA™: …
Roberto is an investor in the biotech space, with +15 years of investing experience spanning from early stage to private equity deals across multiple geographies. He serves on the Board of multiple life-science companies throughout Europe and the US, including Vasopharm GmbH (Germany, traumatic brain injury), GNS Healthcare (Cambridge, digital health), Medinet (UK, outsourcing services). …
Pierfrancesco is CEO of Ricerchimica S.r.l. a consulting company focused on M&A and transaction services in Lifescience. He has over 25-year experience in Pharmaceuticals at European level with particular expertise in the Italian and Spanish market, where Ricerchimica was present, in Barcelona, with their own offices for over 5 years. Pierfrancesco has a wide experience …
Stefano Buono is an accomplished physicist and alumnus of The European Organization for Nuclear Research (CERN). Until January 2018, Mr. Buono served as Chief Executive Officer and board member of Advanced Accelerator Applications (AAA), an international radiopharmaceutical company he founded in 2002. The company traded under the ticker symbol AAAP, until it was acquired by Novartis for $3.9 billion. Mr. Buono …
Fabrizio runs the Italian Life Sciences Corporate Finance practice of EY (f.k.a. Ernst & Young) He has 19 years’ international experience in Corporate Finance, with main focus on M&A, coupled with a deep knowledge of Equity Capital Markets, Private Equity, Debt Advisory, Turnaround, Valuation and Business Modeling Fabrizio has a wealth of transaction experience across …
Chiara is Vice-President of the board of Zambon Company S.p.A., holding of the Group, member of the Board of Directors of Zambon S.p.A. and of ZaCh – Zambon Chemicals. She is also member of the Strategic Advisory Board of Zambon and followed, as member of the Board of Directors, from its origins in 2003, ZCube …
Elena is President President of Zambon S.p.A., Vice President of ZaCh (Zambon Chemicals) and member of the board of Zambon Company S.p.A., holding of the Group. In June 2014 she has been nominated Cavaliere del Lavoro and has received the award “Imprenditore Olivettiano 2010” and “Marisa Belisario 2010”. She is also President of Secofind, member …
